Using the BELOTERO® Range Dr Paula Mann (BDS) provides an overview of the BELOTERO® dermal filler range and explains why she uses the products to create predictable, harmonious results tailored to her individual patient needs
Dr Euan Mackinnon explores if we can achieve surgical outcomes using a non-surgical approach
Aesthetic distributor Merz has launched a dermal filler containing a combination of hyaluronic acid and glycerol called Belotero Revive.
On October 12, aesthetic manufacturer Merz Aesthetics invited eight aesthetic practitioners to attend the first Belotero Lips London Masterclass hosted by nurse prescriber and Merz Innovation Partner Lee Garrett.
Global pharmaceutical company Merz Pharma is constructing a new production plant to produce dermal fillers at its site in Dessau, Germany.
Belotero Balance hyaluronic acid (HA) dermal filler from pharmaceutical company Merz Aesthetics has received US Food and Drug Administration (FDA) approval for under-eye treatments.
Global pharmaceutical company Merz Aesthetics has partnered with actress Gwyneth Paltrow for the company’s first global campaign of its botulinum toxin type A product Xeomin.
Dr Simon and Dr Emma Ravichandran share a case study of using BELOTERO in multiple tissue planes to deliver natural-looking dynamic results
Dr Kim Booysen shares a case study on how fine line correction with BELOTERO Balance is one of her most popular clinic treatments.
Dr Kate Goldie shares her approach to creating harmonious structure and shape with BELOTERO® Volume